Philip Toleikis

Philip Toleikis

Director/Board Member at VENTRIPOINT DIAGNOSTICS LTD.
Health Technology
Consumer Services

Profile

Philip M.
Toleikis
is currently Director at VentriPoint Diagnostics Ltd. since 2026 and a Member of Medway Working Group.
Formerly, Dr. Toleikis was Director & Chief Technology Officer at Sernova Biotherapeutics, Inc. from 2023 to 2024 and VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. in 2006.
Education includes a doctorate from the University of British Columbia, graduate studies at the University of Michigan, and undergraduate studies at the University of Vermont.

Philip Toleikis active positions

CompaniesPositionStart
VENTRIPOINT DIAGNOSTICS LTD. Director/Board Member 2026-07-28
Medway Working Group
Corporate Officer/Principal -

Former positions of Philip Toleikis

CompaniesPositionEnd
SERNOVA BIOTHERAPEUTICS INC Chief Executive Officer 2023-09-04
Chief Tech/Sci/R&D Officer 2005-12-31
See the detail of Philip Toleikis's experience

Training of Philip Toleikis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Medway Working Group

  1. Stock Market
  2. Insiders
  3. Philip Toleikis